Brenda L. Bloodgood
Physiology · 2007–2010
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 10 citations into it
Whom Brenda L. Bloodgood trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Brenda L. Bloodgood overall
Papers from Brenda L. Bloodgood's perspective
Ordered by how strongly the researchers Brenda L. Bloodgood trusts endorse each paper. Same corpus, a different order for every researcher.
- Dendritic spines of CA 1 pyramidal cells in the rat hippocampus: serial electron microscopy with reference to their biophysical characteristics
- Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease (Neurology)
- Dendritic spine changes associated with hippocampal long-term synaptic plasticity
- Bidirectional activity-dependent morphological plasticity in hippocampal neurons. (Neuron)
- Structural basis of long-term potentiation in single dendritic spines (Nature)
- Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. (Proceedings of the National Academy of Sciences of the United States of America)
- Alzheimer's disease: genes, proteins, and therapy. (Physiological Reviews)
- Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo (Nature)
- Natural oligomers of the amyloid-β protein specifically disrupt cognitive function (Nature Neuroscience)
- Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers (Journal of Physiology)
Their papers
- Activity-dependent regulation of inhibitory synapse development by Npas4 (2008) — 625 citations
- The Angelman Syndrome-associated ubiquitin ligase Ube3A regulates synapse development by ubiquitinating Arc (2010) — 610 citations
- Natural Oligomers of the Alzheimer Amyloid-β Protein Induce Reversible Synapse Loss by Modulating an NMDA-Type Glutamate Receptor-Dependent Signaling Pathway (2007) — 1,641 citations